Daily Weight Loss Pill Could Assist Cut Body Weight by 20%, Study Shows

An everyday weight loss tablet could assist individuals reduce their weight by up to 20%, as per a study that could pave the way for millions additional individuals to lose weight.

The Way the Drug Works

The drug, known as orforglipron, focuses on the identical gut hormone pathways as weight loss shots like Mounjaro and semaglutide. During research of 3,127 adults, 20% of people who took the daily tablet for 72 weeks lost at least one-fifth of their body weight.

Weight loss injections are revolutionary, but pill versions are seen as a holy grail since they are easier to keep, share and take, and may also be expected to be cheaper, providing new optimism for millions attempting to reduce weight.

The medication is a GLP-1 agonist, a type of drug that aids in reducing glucose readings, slows the digestion of food and may curb hunger.

Trial Results and Convenience

Slimming results observed in participants taking the tablet is not as stark as that among users using tirzepatide, but specialists believe the oral form is more accessible and user-friendly than shots.

The drug has not been authorized by the US Food and Drug Administration or health authorities in other countries. Developers has said it anticipates significant demand once the oral treatment is released.

In the study, the over three thousand patients were divided into groups receiving orforglipron tablets of different strengths, whereas others received a dummy pill, for the trial period.

All of the patients had obesity, indicating they had a body mass index score of 30 or over, but they did not have diabetes. Patients from several nations were involved in the study.

Significant Results

Scientists discovered that following 72 weeks users on the smallest amount lost an average of nearly 8% of their weight. Those taking the maximum amount shed an average of over 11% of their weight.

In patients using the strongest tablets, more than half had a reduction of 10% or more of weight, 36% had a reduction of 15% or greater, and almost one-fifth had a reduction of 20% or more.

The team reported other health metrics also improved among people taking the medication, including improved blood pressure, a smaller waist circumference and a decrease in LDL levels.

The most common adverse reactions were stomach-related, which were said to be manageable.

“In adults diagnosed with excess weight, long-term use using the medication resulted in significantly greater reductions in weight than placebo,” the authors wrote.

Future Benefits

Health experts have praised weight loss treatments as game-changing. However shots come with additional logistical efforts for medical systems, so oral options could benefit millions more people trying to lose weight.

Separate research indicates weight loss injections may be effective on minors as young as six who have obesity or have type 2 diabetes. However, stomach problems were reported more frequently in young users taking the drugs.

They said that extended observation durations in future trials and additional real-world research were crucial to establish the lasting impacts.”